Active substance
EPLONTERSEN
Therapeutical formulation
INJECTIEVLOEISTOF

€ 36,060.47 € 36,060.47 excluding delivery costs.

This drug is not covered by your health insurance company.

Own risk

Nothing will be charged to your deductible.

Strength
56MG/ML
Supplier
ASTRAZENECA BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/24/1875/001